Albumin levels in acute coronary syndrome
Part of Heart & circulation clinical trials.
This study looks at whether albumin levels in the blood are linked to how serious a heart attack or unstable angina is. If you've been admitted to the hospital with acute coronary syndrome, your albumin levels may be checked to see if they can help predict outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have been diagnosed with acute coronary syndrome (heart attack or unstable angina) and are in the emergency department or coronary care unit.
- You do not have chronic liver disease, nephrotic syndrome, or other conditions that affect albumin levels.
- You are not currently receiving albumin infusions or other treatments that could change your albumin levels.
- You have complete medical records and lab data available.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is checking if a simple blood test (hs-CRP to albumin ratio) can help predict outcomes in people who have had a heart attack or unstable angina but are not getting an immediate balloon/stent procedure. It aims to use inflammation markers to guide better care.
This study looks at whether certain blood markers (related to inflammation and heart damage) can help tell how well your heart is working after a heart attack. By joining, you could help doctors better predict heart function problems and improve care for future patients.
This study is looking at whether changes in a protein called albumin can help find liver disease earlier. It is for people who have some liver scarring but no serious complications.
This study tests whether giving a common fluid (albumin) early can help protect the kidneys in people with advanced liver disease who have a sudden kidney injury. It aims to see if this simple treatment can improve recovery and prevent the need for dialysis.
This trial looks at whether giving or measuring albumin (a blood protein) can help predict outcomes for people with very severe burns in the ICU. It may help doctors understand who is at higher risk and guide care during the first day after injury.
This study looks at whether certain blood markers (white blood cell types compared to albumin) can predict how severe a stroke is and how well a person will recover. It may help doctors better understand stroke outcomes, but eligibility is very strict.
Hear when a new Acute Coronary Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.